Literature DB >> 26210440

Cell membrane-camouflaged nanoparticles for drug delivery.

Brian T Luk1, Liangfang Zhang2.   

Abstract

Nanoparticles can preferentially accumulate at sites of action and hold great promise to improve the therapeutic index of many drugs. While conventional methods of nanocarrier-mediated drug delivery have focused on primarily synthetic approaches, engineering strategies that combine synthetic nanoparticles with natural biomaterials have recently gained much attention. In particular, cell membrane-camouflaged nanoparticles are a new class of biomimetic nanoparticles that combine the unique functionalities of cellular membranes and engineering versatility of synthetic nanomaterials for effective delivery of therapeutic agents. Herein, we report on the recent progress on cell membrane-coated nanoparticles for drug delivery. In particular, we highlight three areas: (i) prolonging systemic circulation via cell membrane coating, (ii) cell-specific targeting via cell membrane coating, and (iii) applications of cell membrane coating for drug delivery. The cell membrane-camouflaged nanoparticle platform has emerged as a novel delivery strategy with the potential to improve the therapeutic efficacy for the treatment of a variety of diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomimetic nanoparticle; Cell membrane; Drug delivery; Nanomedicine; Targeted delivery

Mesh:

Substances:

Year:  2015        PMID: 26210440      PMCID: PMC4688192          DOI: 10.1016/j.jconrel.2015.07.019

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  71 in total

Review 1.  Designing materials for biology and medicine.

Authors:  Robert Langer; David A Tirrell
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  Combinatorial drug conjugation enables nanoparticle dual-drug delivery.

Authors:  Santosh Aryal; Che-Ming Jack Hu; Liangfang Zhang
Journal:  Small       Date:  2010-07-05       Impact factor: 13.281

3.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Liangfang Zhang
Journal:  Nanoscale       Date:  2013-11-26       Impact factor: 7.790

Review 4.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

5.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

6.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor.

Authors:  Ronnie H Fang; Kevin N H Chen; Santosh Aryal; Che-Ming J Hu; Kang Zhang; Liangfang Zhang
Journal:  Langmuir       Date:  2012-09-17       Impact factor: 3.882

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  97 in total

1.  Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.

Authors:  Maria Aurora Grimaudo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.

Authors:  Diana Dehaini; Xiaoli Wei; Ronnie H Fang; Sarah Masson; Pavimol Angsantikul; Brian T Luk; Yue Zhang; Man Ying; Yao Jiang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2017-02-15       Impact factor: 30.849

Review 3.  Nanovaccines for cancer immunotherapy.

Authors:  Yu Zhang; Shuibin Lin; Xiang-Yang Wang; Guizhi Zhu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-06

Review 4.  Direct Drug Targeting into Intracellular Compartments: Issues, Limitations, and Future Outlook.

Authors:  Gamaleldin I Harisa; Tarek M Faris
Journal:  J Membr Biol       Date:  2019-08-02       Impact factor: 1.843

Review 5.  Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines.

Authors:  Danielle M Valcourt; Chintan H Kapadia; Mackenzie A Scully; Megan N Dang; Emily S Day
Journal:  Adv Healthc Mater       Date:  2020-05-04       Impact factor: 9.933

6.  Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.

Authors:  Danielle M Valcourt; Jenna Harris; Rachel S Riley; Megan Dang; Jianxin Wang; Emily S Day
Journal:  Nano Res       Date:  2018-05-17       Impact factor: 8.897

Review 7.  Nanoparticles and direct immunosuppression.

Authors:  Terrika A Ngobili; Michael A Daniele
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

Review 8.  Crosstalk of Nanosystems Induced Extracellular Vesicles as Promising Tools in Biomedical Applications.

Authors:  Gamaleldin I Harisa; Mohamed M Badran; Fars K Alanazi; Sabry M Attia
Journal:  J Membr Biol       Date:  2017-11-10       Impact factor: 1.843

Review 9.  Nanoparticle-hydrogel superstructures for biomedical applications.

Authors:  Yao Jiang; Nishta Krishnan; Jiyoung Heo; Ronnie H Fang; Liangfang Zhang
Journal:  J Control Release       Date:  2020-05-26       Impact factor: 9.776

10.  A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis.

Authors:  Ting Liu; Changzheng Shi; Linqi Duan; Zehang Zhang; Liangping Luo; Shreya Goel; Weibo Cai; Tianfeng Chen
Journal:  J Mater Chem B       Date:  2018-06-29       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.